Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide

An increasing number of older patients with acute myeloid leukemia (AML) are offered an allogeneic hematopoietic stem cell transplantation (allo-HSCT). Normally, older patients have older matched related donors (MRD). Matched unrelated donors (MUD) are an important alternative, but it remains unclea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2024-09, Vol.38 (9), p.2016-2022
Hauptverfasser:	Piemontese, Simona, Labopin, Myriam, Choi, Goda, Broers, Annoek E. C., Peccatori, Jacopo, Meijer, Ellen, Van Gorkom, Gwendolyn, Rovira, Montserrat, Pascual Cascon, Maria Jesús, Sica, Simona, Vydra, Jan, Kulagin, Alexander, Spyridonidis, Alexandros, Nagler, Arnon, Bazarbachi, Ali, Savani, Bipin, Brissot, Eolia, Sanz, Jaime, Mohty, Mohamad, Ciceri, Fabio
Format:	Artikel
Sprache:	eng
Schlagworte:	631/532/1542 631/67/1990/283/1897 Acute myeloid leukemia Allografts Cancer Research Conditioning Critical Care Medicine Cyclophosphamide Donors Graft-versus-host reaction Hematology Hematopoietic stem cells Intensive Internal Medicine Leukemia Medicine Medicine & Public Health Mud Oncology Remission Stem cell transplantation Stem cells Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!